WM:NYSE
Waste Management, Inc.
Data as of 2026-03-10 - not real-time
$246.51
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Waste Management’s stock is trading at $246.51, just shy of its 52‑week high of $248.13, with the 20‑day SMA ($236.38) well below price and a bullish MACD histogram (+1.07) confirming upward momentum. RSI is 73.7, indicating the stock is technically overbought, while volume is on an increasing trend and support sits around $225.36. The company posted 7.1% revenue growth, maintains a solid operating margin of 20% and a free cash flow generation of $1.73 B, supporting a 49% payout ratio and a recent 14.5% dividend increase, suggesting dividend sustainability. However, the DCF‑derived fair value of $21.69 is dramatically lower than the market price, flagging a substantial valuation gap that classifies the stock as overvalued.
The risk profile is muted: beta of 0.17 and a 30‑day volatility of ~19% point to low market sensitivity, and the waste‑management sector is traditionally defensive, yielding a low sector‑risk rating. Regulatory exposure is moderate given the expanding regulated medical‑waste and renewable‑energy businesses, while geographic and currency risks remain low as operations are U.S.‑centric and denominated in USD. Strong ROE (≈30%) and robust cash flow underpin a bullish medium‑ and long‑term thesis, offset by short‑term overbought conditions.
The risk profile is muted: beta of 0.17 and a 30‑day volatility of ~19% point to low market sensitivity, and the waste‑management sector is traditionally defensive, yielding a low sector‑risk rating. Regulatory exposure is moderate given the expanding regulated medical‑waste and renewable‑energy businesses, while geographic and currency risks remain low as operations are U.S.‑centric and denominated in USD. Strong ROE (≈30%) and robust cash flow underpin a bullish medium‑ and long‑term thesis, offset by short‑term overbought conditions.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- RSI in overbought territory
- price near resistance at $248.13
- recent dividend increase signaling confidence
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- strong free cash flow and margin expansion
- defensive sector with low beta
- sustainable dividend payout
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- growth in regulated medical waste and renewable energy assets
- high ROE and consistent earnings growth
- low overall risk and defensive business model
Key Metrics & Analysis
Financial Health
Revenue Growth7.10%
Profit Margin10.74%
P/E Ratio36.8
ROE29.70%
ROA6.49%
Debt/Equity239.38
P/B Ratio9.9
Op. Cash Flow$6.0B
Free Cash Flow$1.7B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI73.7
Support$225.36
Resistance$248.13
MA 20$236.38
MA 50$228.26
MA 200$223.54
MACDBullish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$21.69
Target Price$253.12
Upside/Downside2.68%
GradeOvervalued
TypeBlend
Dividend Yield1.39%
Risk Assessment
Beta0.17
Volatility19.24%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.